This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Close

Theramex News

Our partners

Theramex is a leading global pharmaceutical company dedicated to women and their health, with a reputation for delivering impactful treatments to patients and driving value for our partners.

Learn more

Theramex’s transparent and partnership mindset strikes at every stage of the business relationship starting from deal-making to launch preparations. Theramex teams are brilliant in finding creative solutions to any challenges that your business might face. This attitude is combined with a flexible mindset and an excellent communication skill that is surrounded with a strong specialty commercial infrastructure.

Anil Okay GM, Adalvo and CCO, Alvotech

News

17 June 2022

Theramex Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the treatment of symptoms of Uterine Fibroids

Read more

14 April 2022

Theramex UK Stock Update

Read more

28 March 2022

A consortium of Carlyle and PAI Partners to acquire Theramex from CVC Funds

Read more